Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Supporters often stress the possibility for substantial therapeutic outcomes, particularly in conditions where conventional treatments have proven ineffective. However, this is to consider the substantial financial investment associated with CPI s